Who invested in Lyvgen Biopharma?
Lyvgen Biopharma's investors include IDG Capital and 5Y Capital.

Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2021, from 1 source
Lyvgen Biopharma's investors include IDG Capital and 5Y Capital.
Lyvgen Biopharma has raised $10M across 1 round since 2021.
Lyvgen Biopharma's most recent round was a Series C of $10M in Feb 2021.
Its most recent round, $10M in Feb 2021, is also its largest on record.
Lyvgen Biopharma's first round on record, in Feb 2021, was backed by IDG Capital and 5Y Capital.
Lyvgen Biopharma's latest named round is a Series C, in Feb 2021.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.